Press Release | Longjumeau, France, January 14th 2019
SEQENS. A new name for a global leader in specialty ingredients and pharmaceutical synthesis.
PCAS and all NOVACAP subsidiaries unify their names into a new one and become SEQENS.
SEQENS is an integrated global leader in specialty ingredients and pharmaceutical synthesis, delivering unrivalled market responsiveness and tailor-made solutions to our customers. Read More